|
|
|
201-500 employees
View all
|
|
biotechnology
|
|
US
|
|
ImClone Systems is a fully integrated global biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. On November 24, 2008, ImClone Systems became a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY).
|
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
81.1%
|
The widely used ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company email format is {first}.{last} (e.g. [email protected]) with 81.1% adoption across the company.
To contact ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company customer service number in your country click here to find.
Wu Chen Jia is the CEO of ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.